SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson’s disease
Parkinson’s disease (PD) is one of the most frequent neurological diseases affecting millions of people worldwide. While the majority of PD cases are of unknown origin (idiopathic), about 5%–10% are familial and linked to mutations in different known genes. However, there are also people with a gene...
Main Authors: | Polina Petkova-Kirova, Stephan Baas, Gudrun Wagenpfeil, Philip Hartz, Marcus Michael Unger, Rita Bernhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1244516/full |
Similar Items
-
A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson’s disease
by: Philip Hartz, et al.
Published: (2023-01-01) -
Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer
by: Ying Luo, et al.
Published: (2020-10-01) -
The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases
by: Kai-Di Ni, et al.
Published: (2021-09-01) -
Engineering cytochrome P450s for bioremediation /
by: 242771 Kellner, David G., et al. -
The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
by: Freeborn Rwere, et al.
Published: (2021-09-01)